Keyphrases
Migraine
83%
δ Opioid Receptor
69%
Opioid Receptors
62%
Nitroglycerin
60%
Chronic Migraine
46%
Hyperalgesia
36%
Opioid-induced Hyperalgesia
33%
SNC80
32%
Mouse Model
29%
Trigeminal Ganglion
27%
Opioid Antagonist
23%
μ-opioid Receptor
20%
Headache
19%
Antinociception
18%
Allodynia
17%
Receptor Function
17%
G Protein-coupled Receptor
17%
Arrestin
17%
Cortical Spreading Depression
16%
Morphine
15%
Receptor Agonist
14%
Nucleus Accumbens
14%
Medication Overuse Headache
14%
Chronic Morphine
14%
δ-Opioid Receptor Agonist
14%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
14%
Receptor Trafficking
13%
Opioids
12%
Knock-in Mouse Model
12%
Calcitonin Gene-related Peptide
12%
Behavioral Effects
11%
Post-traumatic Headache
11%
Trigeminal System
11%
Nitric Oxide
11%
Migraine Triggers
11%
Therapeutic Target
11%
Receptor Internalization
10%
Antisense
10%
Dysregulation
10%
Migraine Therapy
9%
Analgesic
9%
Ligand-directed Signaling
9%
Neural Complexity
9%
Histone Deacetylase Inhibitor (HDACi)
9%
Inflammatory Pain
9%
Molecular Mechanism
8%
Enhanced Green Fluorescent Protein (eGFP)
8%
125I
8%
Novel Therapeutic Targets
8%
Acute Migraine Therapy
8%
Neuroscience
Migraine
100%
Receptor
89%
Hyperalgesia
63%
Delta Opiate Receptor
56%
Agonist
52%
Receptor Agonists
44%
Nitroglycerin
39%
Headache
38%
Trigeminal Ganglion
28%
In Vivo
27%
Morphine
23%
G Protein Coupled Receptor
17%
Internalization
16%
Spreading Cortical Depression
15%
μ-Opioid Receptor
14%
Allodynia
14%
Nucleus Accumbens
14%
Retina S Antigen
14%
Nociception
11%
Medication Overuse
11%
Nitric Oxide
11%
Deltorphin
10%
Circadian Rhythm
10%
Alcohol Withdrawal Syndrome
9%
Hypophysis Adenylate Cyclase Activating Polypeptide
9%
Histone Deacetylase Inhibitor
9%
Alternative Splicing
9%
Behavior (Neuroscience)
9%
Receptor Trafficking
9%
Behavioral Effect
8%
Iodine-125
8%
Central Nervous System
7%
Calcitonin
7%
Calcium Channel
7%
Antimigraine
6%
Sensory Neuron
6%
Ventral Tegmental Area
6%
Serotonergic
6%
Nicotinic Receptor
6%
Striatum
5%
Neuropeptide
5%
Enkephalin
5%
In Vitro
5%
Periaqueductal Gray
5%
Drug Therapy
5%
Auras
5%
Convulsant
5%
GABA Receptor
5%
Cerebral Cortex
5%
Pharmacology, Toxicology and Pharmaceutical Science
Migraine
64%
Opiate Receptor
44%
Delta Opiate Receptor
39%
Receptor
34%
Hyperalgesia
29%
Glyceryl Trinitrate
28%
Transformed Migraine
28%
Delta Opiate Receptor Agonist
26%
Mouse Model
21%
Retina S Antigen
18%
G Protein Coupled Receptor
18%
Opiate Agonist
16%
Headache
15%
Opioid-Induced Hyperalgesia
14%
Analgesic Agent
13%
Posttraumatic Headache
12%
Allodynia
12%
Receptor Agonist
10%
Diseases
10%
Histone Deacetylase Inhibitor
9%
Alcohol Withdrawal Syndrome
9%
Drug Induced Headache
9%
Calcium Channel
8%
Morphine
7%
Headache and Facial Pain
7%
Traumatic Brain Injury
6%
Sumatriptan
6%
Chronic Pain
6%
Antinociception
6%
Triptan Derivative
5%
Nitric Oxide
5%
μ-Opioid Receptor
5%
Desensitization
5%
Allyl
5%
Drug Development
5%
Behavioral Effect
5%
Brain Disease
5%
Neuropeptide
5%